These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19509578)

  • 21. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up.
    Argenta PA; Ghebre R; Dusenbery KE; Chen MD; Judson PL; Downs LS; Carson LF
    Eur J Gynaecol Oncol; 2006; 27(3):231-5. PubMed ID: 16800247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer.
    Chen MD; Paley PJ; Potish RA; Twiggs LB
    Gynecol Oncol; 1997 Nov; 67(2):131-6. PubMed ID: 9367695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study.
    Comella G; Frasci G; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Ruffolo P; Comella P
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-113-S12-116. PubMed ID: 9331134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up.
    Nagy VM; Ordeanu C; Coza O; Alin CR; Traila A; Todor N
    Int J Gynecol Cancer; 2012 Nov; 22(9):1538-44. PubMed ID: 23070071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image Guidance Volume-Modulated Arc Radiation Therapy Concurrently With Nab-Paclitaxel Plus Cisplatin for Patients With Locally Advanced Cervical Cancer: A Single-Arm Dose Escalation Trial.
    Jiang P; Deng X; Qu A; Jiang W; Guo F; Han Q; Guo H; Wang J
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1197-1204. PubMed ID: 36402358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.
    Chou HH; Huang HJ; Lin H; Yang LY; Hsueh S; Liu FY; Liou YL; Liou JD; Chen MY; Chao A; Lin G; Chang TC; Lai CH
    Am J Clin Oncol; 2017 Jun; 40(3):241-249. PubMed ID: 25350466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
    Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
    Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study.
    Addeo D; Blank S; Muggia F; Formenti S
    Anticancer Res; 2008; 28(5B):3143-6. PubMed ID: 19031972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group Study.
    Boardman CH; Brady WE; Dizon DS; Kunos CA; Moore KN; Zanotti KM; Matthews C; Cosin JA; Aghajanian C; Fracasso PM
    Gynecol Oncol; 2018 Nov; 151(2):202-207. PubMed ID: 30174176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
    Mundt AJ; Rotmensch J; Waggoner SE; Yamada D; Langhauser C; Fleming GF
    Gynecol Oncol; 2001 Aug; 82(2):333-7. PubMed ID: 11531289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
    Stokes Z; Symonds P; Habeshaw T; Reed N; Curto J; Joynson C; Chan S
    Gynecol Oncol; 2005 Jun; 97(3):790-5. PubMed ID: 15894361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis.
    Chen X; Zou H; Li H; Lin R; Su M; Zhang W; Zhou Y; Zhang P; Hou M; Deng X; Zou C
    Int J Gynecol Cancer; 2017 Feb; 27(2):344-349. PubMed ID: 27984377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin-paclitaxel weekly schedule in advanced solid tumors: a phase I study.
    Frasci G; Comella P; Parziale A; Casaretti R; Daponte A; Gravina A; De Rosa L; Gallipoli A; Comella G
    Ann Oncol; 1997 Mar; 8(3):291-3. PubMed ID: 9137800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity.
    Robert F; Childs HA; Spencer SA; Redden DT; Hawkins MM
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):136-47. PubMed ID: 10210553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.